{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:04:30Z","timestamp":1790337870933,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103593","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:47:02Z","timestamp":1787701622000},"page":"103593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An engineered bacteria-chitosan hybrid robot for lactate depletion and synergistic STING activation to potentiate bladder cancer immunotherapy"],"prefix":"10.1016","volume":"40","author":[{"given":"Baodan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8572-0493","authenticated-orcid":false,"given":"Fangdie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.mtbio.2026.103593_bib1","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103593_bib2","first-page":"507","article-title":"Bladder cancer: diagnosis and treatment","volume":"96","author":"DeGeorge","year":"2017","journal-title":"Am. Fam. Physician"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103593_bib3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","article-title":"Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis","volume":"21","author":"Yin","year":"2016","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103593_bib4","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.4103\/0973-1482.188434","article-title":"Gemcitabine\/cisplatin versus methotrexate\/vinblastine\/doxorubicin\/cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"14","author":"Yu","year":"2018","journal-title":"J. Cancer Res. Therapeut."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103593_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2478\/jtim-2023-0081","article-title":"A cycloruthenated complex, ruthenium (II) Z (RuZ) overcomes in vitro and in vivo multidrug resistance in cancer cells: a pivotal breakthrough","volume":"11","author":"Cao","year":"2023","journal-title":"J. Transl. Intern. Med"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103593_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70531","article-title":"Beyond tumour suppression: cgas-sting pathway in urologic malignancies: context-dependent duality and therapeutic implications","volume":"15","author":"Wei","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"36","key":"10.1016\/j.mtbio.2026.103593_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202405673","article-title":"Interference of ATP-adenosine axis by engineered biohybrid for amplifying immunogenic cell death-mediated antitumor immunotherapy","volume":"36","author":"Deng","year":"2024","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103593_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062800","article-title":"Improving Anti-PD-1\/PD-L1 therapy for localized bladder cancer","volume":"22","author":"de Jong","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"28","key":"10.1016\/j.mtbio.2026.103593_bib9","doi-asserted-by":"crossref","first-page":"24555","DOI":"10.1021\/jacs.5c05148","article-title":"Biomineralized engineered bacterial outer membrane vesicles as cGAS-STING nanoagonists synergize with lactate metabolism modulation to potentiate immunotherapy","volume":"147","author":"Li","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.mtbio.2026.103593_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating particulate drug delivery","volume":"98","author":"Netsomboon","year":"2016","journal-title":"Eur. J. Pharm. Biopharm: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2026.103593_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.05.014","article-title":"Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: safety and efficacy","volume":"471","author":"Erdogar","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2026.103593_bib12","article-title":"Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets","volume":"48","author":"Yang","year":"2025","journal-title":"Genes & genomics"},{"issue":"23","key":"10.1016\/j.mtbio.2026.103593_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238993","article-title":"Treatment strategies and metabolic pathway regulation in urothelial cell carcinoma: a comprehensive review","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103593_bib14","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/ijc.33359","article-title":"Recurrent bladder cancer in aging societies: importance of major histocompatibility complex class I antigen presentation","volume":"148","author":"Wieczorek","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103593_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/mr-2024-0041","article-title":"Precision phototherapy and imaging with aggregation-induced emission-based nanoparticles cloaked in macrophage membrane","volume":"5","author":"Shubhra","year":"2025","journal-title":"Med. rev."},{"key":"10.1016\/j.mtbio.2026.103593_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mattod.2025.03.018","article-title":"Engineered radiation-sensitive probiotic for synergistic tumor cell cycle blockade and immunomodulation to potentiate radio-immunotherapy in pancreatic cancer","volume":"86","author":"Yao","year":"2025","journal-title":"Mater. Today"},{"key":"10.1016\/j.mtbio.2026.103593_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123075","article-title":"Bimetallic nanoreactor mediates cascade amplification of oxidative stress for complementary chemodynamic-immunotherapy of tumor","volume":"317","author":"Zhou","year":"2025","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.mtbio.2026.103593_bib18","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","article-title":"NAT10 drives cisplatin chemoresistance by enhancing ac4C-Associated DNA repair in bladder cancer","volume":"83","author":"Xie","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103593_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-022-01517-9","article-title":"Targeting HNRNPU to overcome cisplatin resistance in bladder cancer","volume":"21","author":"Shi","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103593_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-025-03487-4","article-title":"Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"issue":"22","key":"10.1016\/j.mtbio.2026.103593_bib21","article-title":"Targeting the KAT8\/YEATS4 axis represses tumor growth and increases cisplatin sensitivity in bladder cancer","volume":"11","author":"Xie","year":"2024","journal-title":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103593_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317691679","article-title":"Downregulated XPA promotes carcinogenesis of bladder cancer via impairment of DNA repair","volume":"39","author":"Zhi","year":"2017","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103593_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11934-024-01242-4","article-title":"Impact of DNA repair deficiency in the evolving treatment landscape of bladder cancer","volume":"26","author":"D'Andrea","year":"2024","journal-title":"Curr. Urol. Rep."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103593_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103593_bib25","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41467-023-41218-5","article-title":"AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103593_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009368","article-title":"Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy","volume":"12","author":"Al-Janabi","year":"2024","journal-title":"J. ImmunoTher. Cancer"},{"issue":"7931","key":"10.1016\/j.mtbio.2026.103593_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-022-05254-3","article-title":"STING-induced regulatory B cells compromise NK function in cancer immunity","volume":"610","author":"Li","year":"2022","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.mtbio.2026.103593_bib28","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1158\/1078-0432.CCR-23-1439","article-title":"SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression","volume":"29","author":"Geng","year":"2023","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Res."},{"issue":"13","key":"10.1016\/j.mtbio.2026.103593_bib29","doi-asserted-by":"crossref","first-page":"eaay9789","DOI":"10.1126\/sciadv.aay9789","article-title":"Irradiated tumor cell-derived microparticles mediate tumor eradication via cell killing and immune reprogramming","volume":"6","author":"Wan","year":"2020","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103593_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103593_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yexcr.2016.01.005","article-title":"Metabolic alterations in bladder cancer: applications for cancer imaging","volume":"341","author":"Whyard","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103593_bib32","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/cam4.1109","article-title":"Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer","volume":"6","author":"Sahu","year":"2017","journal-title":"Cancer Med."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103593_bib33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103593_bib34","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1016\/j.clgc.2019.03.009","article-title":"PD-1\/PD-L1 combinations in advanced urothelial cancer: Rationale and current clinical trials","volume":"17","author":"Hsu","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"issue":"3191","key":"10.1016\/j.mtbio.2026.103593_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103593_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.celrep.2019.08.068","article-title":"Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy","volume":"29","author":"Renner","year":"2019","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103593_bib37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s42255-020-0219-4","article-title":"Inosine is an alternative carbon source for CD8(+)-T-cell function under glucose restriction","volume":"2","author":"Wang","year":"2020","journal-title":"Nat. Metab."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103593_bib38","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103593_bib39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103593_bib40","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.mtbio.2026.103593_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002202","article-title":"Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions","volume":"13","author":"Haas","year":"2015","journal-title":"PLoS Biol."},{"issue":"6","key":"10.1016\/j.mtbio.2026.103593_bib42","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","article-title":"Neutralization of tumor acidity improves antitumor responses to immunotherapy","volume":"76","author":"Pilon-Thomas","year":"2016","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103593_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040450","article-title":"Blockade of lactate Dehydrogenase-A (LDH-A) improves efficacy of anti-programmed cell Death-1 (PD-1) therapy in Melanoma","volume":"11","author":"Daneshmandi","year":"2019","journal-title":"Cancers"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426008380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426008380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:41:44Z","timestamp":1790336504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426008380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S2590006426008380"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103593","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An engineered bacteria-chitosan hybrid robot for lactate depletion and synergistic STING activation to potentiate bladder cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103593"}}